최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Virulence, v.4 no.3, 2013년, pp.230 - 240
Iovine, Nicole M. (University of Florida and the Malcom Randall VA Medical Center)
Campylobacter jejuni is a major cause of food-borne gastroenteritis worldwide. While mortality is low, morbidity imparted by post-infectious sequelae such as Guillain-Barré syndrome, Reiter syndrome/reactive arthritis and irritable bowel syndrome is significant. In addition, the economic cost...
1 Zilbauer M Dorrell N Wren BW Bajaj-Elliott M Campylobacter jejuni-mediated disease pathogenesis: an update Trans R Soc Trop Med Hyg 2008 102 123 9 10.1016/j.trstmh.2007.09.019 18023831
2 Eurosurveillance editorial team The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010 Euro Surveill 2012 17 20113 22433599
3 EFSA The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2008 Eur Food Safety Auth J 2010 8 1658 919
4 OzFoodNet Working Group Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009 Commun Dis Intell 2010 34 396 426 21413526
5 Notifiable and Other Diseases in New Zealand. Annula Report 2011. In: The Institute of Environmental Science and Research Ltd. Porirua, New Zealand; 2012.
6 Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandell, ed. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2010:2793-802.
7 Blaser MJ Taylor DN Feldman RA Epidemiology of Campylobacter jejuni infections Epidemiol Rev 1983 5 157 76 6357819
8 Centers for Disease Control and Prevention (CDC) Incidence of foodborne illnesses: preliminary data from the Foodborne Diseases Active Surveillance Network (FoodNet)--United States, 1998 MMWR Morb Mortal Wkly Rep 1999 48 189 94 10208124
9 FoodNet - Foodborne Diseases Active Surveillance Network. Centers for Disease Control and Prevention, 2012. (Accessed March 14, 2012, at http://www.cdc.gov/foodnet/ )
10 Thomas C Gibson H Hill DJ Mabey M Campylobacter epidemiology: an aquatic perspective J Appl Microbiol 1998 85 Suppl 1 168S 77S 10.1111/j.1365-2672.1998.tb05296.x 21182706
12 Gupta A Nelson JM Barrett TJ Tauxe RV Rossiter SP Friedman CR NARMS Working Group Antimicrobial resistance among Campylobacter strains, United States, 1997-2001 Emerg Infect Dis 2004 10 1102 9 10.3201/eid1006.030635 15207064
13 Luangtongkum T Jeon B Han J Plummer P Logue CM Zhang Q Antibiotic resistance in Campylobacter: emergence, transmission and persistence Future Microbiol 2009 4 189 200 10.2217/17460913.4.2.189 19257846
14 Smith KE Besser JM Hedberg CW Leano FT Bender JB Wicklund JH Investigation Team Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998 N Engl J Med 1999 340 1525 32 10.1056/NEJM199905203402001 10332013
15 Threlfall EJ Ward LR Frost JA Willshaw GA Spread of resistance from food animals to man--the UK experience Acta Vet Scand Suppl 2000 93 63 8, discussion 68-74 10822859
16 van Boven M Veldman KT de Jong MC Mevius DJ Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers J Antimicrob Chemother 2003 52 719 23 10.1093/jac/dkg402 12951353
17 Hooper DC Emerging mechanisms of fluoroquinolone resistance Emerg Infect Dis 2001 7 337 41 10.3201/eid0702.010239 11294736
18 Moore JE Barton MD Blair IS Corcoran D Dooley JS Fanning S The epidemiology of antibiotic resistance in Campylobacter Microbes Infect 2006 8 1955 66 10.1016/j.micinf.2005.12.030 16716632
19 Kittl S Kuhnert P Hächler H Korczak BM Comparison of genotypes and antibiotic resistance of Campylobacter jejuni isolated from humans and slaughtered chickens in Switzerland J Appl Microbiol 2011 110 513 20 10.1111/j.1365-2672.2010.04906.x 21143711
20 Monitoring antimicrobial usage in food animals for the protection of human health: Report of a WHO consultation. World Health Organization Department of Communicable Disease, Surveillance and Response 2001.
21 Guerrant RL Van Gilder T Steiner TS Thielman NM Slutsker L Tauxe RV Infectious Diseases Society of America Practice guidelines for the management of infectious diarrhea Clin Infect Dis 2001 32 331 51 10.1086/318514 11170940
22 Sarmah AK Meyer MT Boxall AB A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment Chemosphere 2006 65 725 59 10.1016/j.chemosphere.2006.03.026 16677683
23 Council regulation (EC) No. 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorization of certain antibiotics, Directive 70/524/EEC concerning additives in feedingstuffs Official Journal of the European Communities 1998 351 4 8
24 Ansary A Radu S Conjugal transfer of antibiotic resistances and plasmids from Campylobacter jejuni clinical isolates FEMS Microbiol Lett 1992 70 125 8 10.1111/j.1574-6968.1992.tb05196.x 1587459
25 Bradbury WC Munroe DL Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals J Clin Microbiol 1985 22 339 46 4044793
26 Gibreel A Sköld O High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases Antimicrob Agents Chemother 1998 42 3059 64 9835491
27 Gibreel A Sköld O Taylor DE Characterization of plasmid-mediated aphA-3 kanamycin resistance in Campylobacter jejuni Microb Drug Resist 2004 10 98 105 10.1089/1076629041310127 15256024
28 Gibreel A Tracz DM Nonaka L Ngo TM Connell SR Taylor DE Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance Antimicrob Agents Chemother 2004 48 3442 50 10.1128/AAC.48.9.3442-3450.2004 15328109
29 Lambert T Gerbaud G Trieu-Cuot P Courvalin P Structural relationship between the genes encoding 3′-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci Ann Inst Pasteur Microbiol 1985 136B 135 50 10.1016/S0769-2609(85)80040-5 3002237
30 Lee MD Sanchez S Zimmer M Idris U Berrang ME McDermott PF Class 1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment Antimicrob Agents Chemother 2002 46 3660 4 10.1128/AAC.46.11.3660-3664.2002 12384387
31 Nirdnoy W Mason CJ Guerry P Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni Antimicrob Agents Chemother 2005 49 2454 9 10.1128/AAC.49.6.2454-2459.2005 15917546
32 O’Halloran F Lucey B Cryan B Buckley T Fanning S Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp J Antimicrob Chemother 2004 53 952 7 10.1093/jac/dkh193 15128721
33 Pinto-Alphandary H Mabilat C Courvalin P Emergence of aminoglycoside resistance genes aadA and aadE in the genus Campylobacter Antimicrob Agents Chemother 1990 34 1294 6 10.1128/AAC.34.6.1294 2168151
34 Sagara H Mochizuki A Okamura N Nakaya R Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates Antimicrob Agents Chemother 1987 31 713 9 10.1128/AAC.31.5.713 3038005
35 Velázquez JB Jiménez A Chomón B Villa TG Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli J Antimicrob Chemother 1995 35 173 8 10.1093/jac/35.1.173 7768766
36 Lin J Michel LO Zhang Q CmeABC functions as a multidrug efflux system in Campylobacter jejuni Antimicrob Agents Chemother 2002 46 2124 31 10.1128/AAC.46.7.2124-2131.2002 12069964
37 Pumbwe L Piddock LJ Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump FEMS Microbiol Lett 2002 206 185 9 10.1111/j.1574-6968.2002.tb11007.x 11814661
38 Lin J Sahin O Michel LO Zhang Q Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni Infect Immun 2003 71 4250 9 10.1128/IAI.71.8.4250-4259.2003 12874300
39 Akiba M Lin J Barton YW Zhang Q Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni J Antimicrob Chemother 2006 57 52 60 10.1093/jac/dki419 16303882
40 Jeon B Wang Y Hao H Barton YW Zhang Q Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni J Antimicrob Chemother 2011 66 79 85 10.1093/jac/dkq418 21081547
41 Parkhill J Wren BW Mungall K Ketley JM Churcher C Basham D The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences Nature 2000 403 665 8 10.1038/35001088 10688204
42 Corcoran D Quinn T Cotter L Fanning S An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter Int J Antimicrob Agents 2006 27 40 5 10.1016/j.ijantimicag.2005.08.019 16318913
43 Kurincic M Botteldoorn N Herman L Smole Mozina S Mechanisms of erythromycin resistance of Campylobacter spp. isolated from food, animals and humans Int J Food Microbiol 2007 120 186 90 10.1016/j.ijfoodmicro.2007.03.012 17889390
44 Pumbwe L Randall LP Woodward MJ Piddock LJ Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni J Antimicrob Chemother 2004 54 341 7 10.1093/jac/dkh331 15201231
45 Page WJ Huyer G Huyer M Worobec EA Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility Antimicrob Agents Chemother 1989 33 297 303 10.1128/AAC.33.3.297 2543277
46 Jeon B Muraoka W Scupham A Zhang Q Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni J Antimicrob Chemother 2009 63 462 8 10.1093/jac/dkn529 19147521
47 Karmali MA De Grandis S Fleming PC Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates Antimicrob Agents Chemother 1981 19 593 7 10.1128/AAC.19.4.593 7247381
48 Keo T Collins J Kunwar P Blaser MJ Iovine NM Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials Virulence 2011 2 30 40 10.4161/viru.2.1.14752 21266840
49 Taylor DE Ng LK Lior H Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors Antimicrob Agents Chemother 1985 28 708 10 10.1128/AAC.28.5.708 3004325
50 van Mourik A Steeghs L van Laar J Meiring HD Hamstra HJ van Putten JP Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance J Biol Chem 2010 285 15828 36 10.1074/jbc.M110.102061 20351099
51 Akhtar SQ Antimicrobial sensitivity and plasmid-mediated tetracycline resistance in Campylobacter jejuni isolated in Bangladesh Chemotherapy 1988 34 326 31 10.1159/000238587 3208549
52 Boonmar S Sangsuk L Suthivarakom K Padungtod P Morita Y Serotypes and antimicrobial resistance of Campylobacter jejuni isolated from humans and animals in Thailand Southeast Asian J Trop Med Public Health 2005 36 130 4 15906655
53 Hoge CW Gambel JM Srijan A Pitarangsi C Echeverria P Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years Clin Infect Dis 1998 26 341 5 10.1086/516303 9502453
54 National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). Human Isolates Final Report, 2010. U.S. Department of Health and Human Services, CDC, 2012. (Accessed at http://www.cdc.gov/narms/reports.htm )
55 DANMAP. 2011. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. In: The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme; 2012.
56 Van Looveren M Daube G De Zutter L Dumont JM Lammens C Wijdooghe M Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium J Antimicrob Chemother 2001 48 235 40 10.1093/jac/48.2.235 11481294
57 Davidson D. In the matter of enrofloxacin for poultry: Withdrawal of approval of Bayer Corporation's new animal drug application 1 (NADA) 140-828 (Baytril). In: FDA Docket No 00N-1571 2004; 2004.
58 Miflin JK Templeton JM Blackall PJ Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from poultry in the South-East Queensland region J Antimicrob Chemother 2007 59 775 8 10.1093/jac/dkm024 17392353
59 Unicomb LE Ferguson J Stafford RJ Ashbolt R Kirk MD Becker NG Australian Campylobacter Subtyping Study Group Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia Clin Infect Dis 2006 42 1368 74 10.1086/503426 16619147
60 Norström M Hofshagen M Stavnes T Schau J Lassen J Kruse H Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway Epidemiol Infect 2006 134 127 30 10.1017/S0950268805004814 16409659
61 Jain D Sinha S Prasad KN Pandey CM Campylobacter species and drug resistance in a north Indian rural community Trans R Soc Trop Med Hyg 2005 99 207 14 10.1016/j.trstmh.2004.09.006 15653123
62 Bester LA Essack SY Observational study of the prevalence and antibiotic resistance of Campylobacter spp. from different poultry production systems in KwaZulu-Natal, South Africa J Food Prot 2012 75 154 9 10.4315/0362-028X.JFP-11-237 22221370
63 Chokboonmongkol C Patchanee P Gölz G Zessin KH Alter T Prevalence, quantitative load, and antimicrobial resistance of Campylobacter spp. from broiler ceca and broiler skin samples in Thailand Poult Sci 2013 92 462 7 10.3382/ps.2012-02599 23300314
64 Haruna M Sasaki Y Murakami M Ikeda A Kusukawa M Tsujiyama Y Prevalence and antimicrobial susceptibility of Campylobacter in broiler flocks in Japan Zoonoses Public Health 2012 59 241 5 10.1111/j.1863-2378.2011.01441.x 22103704
65 Wardak S Szych J Zasada AA Gierczynski R Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland Antimicrob Agents Chemother 2007 51 1123 5 10.1128/AAC.01187-06 17210776
66 Sáenz Y Zarazaga M Lantero M Gastanares MJ Baquero F Torres C Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998 Antimicrob Agents Chemother 2000 44 267 71 10.1128/AAC.44.2.267-271.2000 10639348
67 Griggs DJ Johnson MM Frost JA Humphrey T Jørgensen F Piddock LJ Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment Antimicrob Agents Chemother 2005 49 699 707 10.1128/AAC.49.2.699-707.2005 15673754
68 Price LB Johnson E Vailes R Silbergeld E Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products Environ Health Perspect 2005 113 557 60 10.1289/ehp.7647 15866763
69 Price LB Lackey LG Vailes R Silbergeld E The persistence of fluoroquinolone-resistant Campylobacter in poultry production Environ Health Perspect 2007 115 1035 9 10.1289/ehp.10050 17637919
70 Zhang Q Lin J Pereira S Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness Anim Health Res Rev 2003 4 63 71 10.1079/AHR200356 15134291
71 Luo N Pereira S Sahin O Lin J Huang S Michel L Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure Proc Natl Acad Sci U S A 2005 102 541 6 10.1073/pnas.0408966102 15634738
72 Ge B McDermott PF White DG Meng J Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli Antimicrob Agents Chemother 2005 49 3347 54 10.1128/AAC.49.8.3347-3354.2005 16048946
73 Luo N Sahin O Lin J Michel LO Zhang Q In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump Antimicrob Agents Chemother 2003 47 390 4 10.1128/AAC.47.1.390-394.2003 12499221
74 Yan M Sahin O Lin J Zhang Q Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure J Antimicrob Chemother 2006 58 1154 9 10.1093/jac/dkl412 17023497
75 Drlica K Zhao X DNA gyrase, topoisomerase IV, and the 4-quinolones Microbiol Mol Biol Rev 1997 61 377 92 9293187
76 Shea ME Hiasa H Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes J Biol Chem 1999 274 22747 54 10.1074/jbc.274.32.22747 10428858
77 Willmott CJ Critchlow SE Eperon IC Maxwell A The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase J Mol Biol 1994 242 351 63 10.1006/jmbi.1994.1586 7932695
78 Bachoual R Ouabdesselam S Mory F Lascols C Soussy CJ Tankovic J Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli Microb Drug Resist 2001 7 257 61 10.1089/10766290152652800 11759087
79 Cooper R Segal H Lastovica AJ Elisha BG Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains J Appl Microbiol 2002 93 241 9 10.1046/j.1365-2672.2002.01650.x 12147072
80 Payot S Cloeckaert A Chaslus-Dancla E Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin Microb Drug Resist 2002 8 335 43 10.1089/10766290260469606 12523631
81 Gootz TD Martin BA Characterization of high-level quinolone resistance in Campylobacter jejuni Antimicrob Agents Chemother 1991 35 840 5 10.1128/AAC.35.5.840 1649570
82 Jesse TW Englen MD Pittenger-Alley LG Fedorka-Cray PJ Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle J Appl Microbiol 2006 100 682 8 10.1111/j.1365-2672.2005.02796.x 16553723
83 Farnell MB Donoghue AM Cole K Reyes-Herrera I Blore PJ Donoghue DJ Campylobacter susceptibility to ciprofloxacin and corresponding fluoroquinolone concentrations within the gastrointestinal tracts of chickens J Appl Microbiol 2005 99 1043 50 10.1111/j.1365-2672.2005.02712.x 16238734
84 McDermott PF Bodeis SM English LL White DG Walker RD Zhao S Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones J Infect Dis 2002 185 837 40 10.1086/339195 11920303
85 Takahashi T Ishihara K Kojima A Asai T Harada K Tamura Y Emergence of fluoroquinolone resistance in Campylobacter jejuni in chickens exposed to enrofloxacin treatment at the inherent dosage licensed in Japan J Vet Med B Infect Dis Vet Public Health 2005 52 460 4 10.1111/j.1439-0450.2005.00890.x 16364022
86 Ellis-Pegler RB Hyman LK Ingram RJ McCarthy M A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community J Antimicrob Chemother 1995 36 259 63 10.1093/jac/36.1.259 8537277
87 Segreti J Gootz TD Goodman LJ Parkhurst GW Quinn JP Martin BA High-level quinolone resistance in clinical isolates of Campylobacter jejuni J Infect Dis 1992 165 667 70 10.1093/infdis/165.4.667 1313069
88 Wretlind B Strömberg A Ostlund L Sjögren E Kaijser B Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin Scand J Infect Dis 1992 24 685 6 10.3109/00365549209054659 1465591
89 Ruiz J Goñi P Marco F Gallardo F Mirelis B Jimenez De Anta T Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates Microbiol Immunol 1998 42 223 6 9580533
90 Wang Y Huang WM Taylor DE Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations Antimicrob Agents Chemother 1993 37 457 63 10.1128/AAC.37.3.457 8384814
91 Piddock LJ Ricci V Pumbwe L Everett MJ Griggs DJ Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes J Antimicrob Chemother 2003 51 19 26 10.1093/jac/dkg033 12493783
92 Engberg J Neimann J Nielsen EM Aerestrup FM Fussing V Quinolone-resistant Campylobacter infections: risk factors and clinical consequences Emerg Infect Dis 2004 10 1056 63 10.3201/eid1006.030669 15207057
93 Feodoroff FB Lauhio AR Sarna SJ Hänninen ML Rautelin HI Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates Clin Microbiol Infect 2009 15 188 92 10.1111/j.1469-0691.2008.02657.x 19154485
94 Helms M Simonsen J Olsen KE Mølbak K Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study J Infect Dis 2005 191 1050 5 10.1086/428453 15747238
95 Nelson JM Smith KE Vugia DJ Rabatsky-Ehr T Segler SD Kassenborg HD Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection J Infect Dis 2004 190 1150 7 10.1086/423282 15319866
96 Sonnevend A Kovács J Pál T Akawi N Nagelkerke N Schneider G Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance Scand J Infect Dis 2011 43 905 11 10.3109/00365548.2011.603743 21905953
97 Wassenaar TM Kist M de Jong A Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections Int J Antimicrob Agents 2007 30 195 201 10.1016/j.ijantimicag.2007.01.019 17420115
98 Asai T Harada K Ishihara K Kojima A Sameshima T Tamura Y Association of antimicrobial resistance in Campylobacter isolated from food-producing animals with antimicrobial use on farms Jpn J Infect Dis 2007 60 290 4 17881869
99 Animal Drugs @ FDA. Center for Veterinary Medicine, 2012. (Accessed at http://www.accessdata.fda.gov/scripts/animaldrugsatfda/index.cfm )
100 Cagliero C Mouline C Cloeckaert A Payot S Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli Antimicrob Agents Chemother 2006 50 3893 6 10.1128/AAC.00616-06 16940070
101 Lin J Yan M Sahin O Pereira S Chang YJ Zhang Q Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens Antimicrob Agents Chemother 2007 51 1678 86 10.1128/AAC.01411-06 17353243
102 Payot S Bolla JM Corcoran D Fanning S Mégraud F Zhang Q Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp Microbes Infect 2006 8 1967 71 10.1016/j.micinf.2005.12.032 16713726
103 Egger R Korczak BM Niederer L Overesch G Kuhnert P Genotypes and antibiotic resistance of Campylobacter coli in fattening pigs Vet Microbiol 2012 155 272 8 10.1016/j.vetmic.2011.08.012 21899961
104 Gibreel A Taylor DE Macrolide resistance in Campylobacter jejuni and Campylobacter coli J Antimicrob Chemother 2006 58 243 55 10.1093/jac/dkl210 16735431
105 Lachance N Gaudreau C Lamothe F Larivière LA Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents Antimicrob Agents Chemother 1991 35 813 8 10.1128/AAC.35.5.813 1854162
106 Lehtopolku M Kotilainen P Haanperä-Heikkinen M Nakari UM Hänninen ML Huovinen P Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli Antimicrob Agents Chemother 2011 55 5939 41 10.1128/AAC.00314-11 21911571
107 Mamelli L Prouzet-Mauléon V Pagès JM Mégraud F Bolla JM Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations J Antimicrob Chemother 2005 56 491 7 10.1093/jac/dki253 16055509
108 Pérez-Boto D López-Portolés JA Simón C Valdezate S Echeita MA Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains J Antimicrob Chemother 2010 65 2083 8 10.1093/jac/dkq268 20647243
109 Ren GW Wang Y Shen Z Chen X Shen J Wu C Rapid detection of point mutations in domain V of the 23S rRNA gene in erythromycin-resistant Campylobacter isolates by pyrosequencing Foodborne Pathog Dis 2011 8 375 9 10.1089/fpd.2010.0676 21166562
110 Vacher S Menard A Bernard E Santos A Megraud F Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR Microb Drug Resist 2005 11 40 7 10.1089/mdr.2005.11.40 15770093
111 Fouts DE Mongodin EF Mandrell RE Miller WG Rasko DA Ravel J Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species PLoS Biol 2005 3 e15 10.1371/journal.pbio.0030015 15660156
112 Gibreel A Wetsch NM Taylor DE Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni Antimicrob Agents Chemother 2007 51 3212 6 10.1128/AAC.01592-06 17606685
113 Payot S Avrain L Magras C Praud K Cloeckaert A Chaslus-Dancla E Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli Int J Antimicrob Agents 2004 23 468 72 10.1016/j.ijantimicag.2003.12.008 15120725
114 Logue CM Danzeisen GT Sherwood JS Thorsness JL Mercier BM Axtman JE Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility J Appl Microbiol 2010 109 1379 88 10.1111/j.1365-2672.2010.04765.x 20497488
115 Almofti YA Dai M Sun Y Haihong H Yuan Z Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni Microb Pathog 2011 50 336 42 10.1016/j.micpath.2011.02.009 21377522
116 Han F Pu S Wang F Meng J Ge B Fitness cost of macrolide resistance in Campylobacter jejuni Int J Antimicrob Agents 2009 34 462 6 10.1016/j.ijantimicag.2009.06.019 19651494
117 Hao H Dai M Wang Y Peng D Liu Z Yuan Z 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni Microb Drug Resist 2009 15 239 44 10.1089/mdr.2009.0008 19857128
118 Zeitouni S Collin O Andraud M Ermel G Kempf I Fitness of macrolide resistant Campylobacter coli and Campylobacter jejuni Microb Drug Resist 2012 18 101 8 10.1089/mdr.2011.0188 22324770
119 EFSA The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010 Eur Food Safety Auth J 2012 10 2598 830
120 Smith SI Sansa TI Coker AO Antibiotic susceptibility patterns and beta-lactamase production of animal and human isolates of Campylobacter in Lagos, Nigeria Z Naturforsch C 1999 54 583 6 10488568
121 Gibreel A Kos VN Keelan M Trieber CA Levesque S Michaud S Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype Antimicrob Agents Chemother 2005 49 2753 9 10.1128/AAC.49.7.2753-2759.2005 15980346
122 Caldwell DB Wang Y Lin J Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni Antimicrob Agents Chemother 2008 52 3947 54 10.1128/AAC.00450-08 18779354
123 Jeon B Zhang Q Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter J Antimicrob Chemother 2009 63 946 8 10.1093/jac/dkp067 19279049
124 Huyer MP Hancock T Page RW Outer membrane porin protein of Campylobacter jejuni. FEMS Microbiol Lett 1986 37 247 50 10.1111/j.1574-6968.1986.tb01803.x
125 Hancock RE Bell A Antibiotic uptake into gram-negative bacteria Eur J Clin Microbiol Infect Dis 1988 7 713 20 10.1007/BF01975036 2850910
126 Vaara M Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria Antimicrob Agents Chemother 1993 37 354 6 10.1128/AAC.37.2.354 8383945
127 Logan SM Trust TJ Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli Infect Immun 1984 45 210 6 6203838
128 Naess V Hofstad T Isolation and chemical composition of lipopolysaccharide from Campylobacter jejuni Acta Pathol Microbiol Immunol Scand B 1982 90 135 9 7080831
129 Giesbrecht P Kersten T Maidhof H Wecke J Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin Microbiol Mol Biol Rev 1998 62 1371 414 9841676
130 Alfredson DA Korolik V Isolation and expression of a novel molecular class D beta-lactamase, OXA-61, from Campylobacter jejuni Antimicrob Agents Chemother 2005 49 2515 8 10.1128/AAC.49.6.2515-2518.2005 15917560
131 Griggs DJ Peake L Johnson MM Ghori S Mott A Piddock LJ Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni Antimicrob Agents Chemother 2009 53 3357 64 10.1128/AAC.01655-08 19506058
132 Lachance N Gaudreau C Lamothe F Turgeon F Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents Antimicrob Agents Chemother 1993 37 1174 6 10.1128/AAC.37.5.1174 8390812
133 Tajada P Gomez-Graces JL Alós JI Balas D Cogollos R Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors Antimicrob Agents Chemother 1996 40 1924 5 8843305
134 Wright EP Knowles MA Beta-lactamase production by Campylobacter jejuni J Clin Pathol 1980 33 904 5 10.1136/jcp.33.9.904-b 6968758
135 Alfredson DA Korolik V Identification of putative zinc hydrolase genes of the metallo-beta-lactamase superfamily from Campylobacter jejuni FEMS Immunol Med Microbiol 2007 49 159 64 10.1111/j.1574-695X.2006.00197.x 17266723
136 Potter ME Blaser MJ Sikes RK Kaufmann AF Wells JG Human Campylobacter infection associated with certified raw milk Am J Epidemiol 1983 117 475 83 6837559
137 Chopra I Roberts M Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance [second page, table of contents.] Microbiol Mol Biol Rev 2001 65 232 60 10.1128/MMBR.65.2.232-260.2001 11381101
138 Bolla JM Loret E Zalewski M Pagés JM Conformational analysis of the Campylobacter jejuni porin J Bacteriol 1995 177 4266 71 7543469
139 Kervella M Fauchère JL Fourel D Pagès JM Immunological cross-reactivity between outer membrane pore proteins of Campylobacter jejuni and Escherichia coli FEMS Microbiol Lett 1992 78 281 5 10.1111/j.1574-6968.1992.tb05582.x 1337053
140 Epe B Woolley P Hornig H Competition between tetracycline and tRNA at both P and A sites of the ribosome of Escherichia coli FEBS Lett 1987 213 443 7 10.1016/0014-5793(87)81539-9 3104093
141 Goldman RA Hasan T Hall CC Strycharz WA Cooperman BS Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis Biochemistry 1983 22 359 68 10.1021/bi00271a020 6337627
142 Manavathu EK Hiratsuka K Taylor DE Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni Gene 1988 62 17 26 10.1016/0378-1119(88)90576-8 2836268
143 Salyers AA Speer BS Shoemaker NB New perspectives in tetracycline resistance Mol Microbiol 1990 4 151 6 10.1111/j.1365-2958.1990.tb02025.x 2181236
144 Dasti JI Gross U Pohl S Lugert R Weig M Schmidt-Ott R Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli J Med Microbiol 2007 56 833 7 10.1099/jmm.0.47103-0 17510271
145 Taylor DE Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant J Bacteriol 1986 165 1037 9 3005233
146 Batchelor RA Pearson BM Friis LM Guerry P Wells JM Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species Microbiology 2004 150 3507 17 10.1099/mic.0.27112-0 15470128
147 Taylor DE Courvalin P Mechanisms of antibiotic resistance in Campylobacter species Antimicrob Agents Chemother 1988 32 1107 12 10.1128/AAC.32.8.1107 3056250
148 Sahin O Plummer PJ Jordan DM Sulaj K Pereira S Robbe-Austerman S Emergence of a tetracycline-resistant Campylobacter jejuni clone associated with outbreaks of ovine abortion in the United States J Clin Microbiol 2008 46 1663 71 10.1128/JCM.00031-08 18322054
149 Bérdy J. CRC handbook of antibiotic compounds. Boca Raton, Fla.: CRC Press; 1980.
150 Jana S Deb JK Molecular understanding of aminoglycoside action and resistance Appl Microbiol Biotechnol 2006 70 140 50 10.1007/s00253-005-0279-0 16391922
151 Taber HW Mueller JP Miller PF Arrow AS Bacterial uptake of aminoglycoside antibiotics Microbiol Rev 1987 51 439 57 3325794
152 Bryan LE Kwan S Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin Antimicrob Agents Chemother 1983 23 835 45 10.1128/AAC.23.6.835 6351731
154 Hermann T Aminoglycoside antibiotics: old drugs and new therapeutic approaches Cell Mol Life Sci 2007 64 1841 52 10.1007/s00018-007-7034-x 17447006
155 Ouellette M Gerbaud G Lambert T Courvalin P Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae Antimicrob Agents Chemother 1987 31 1021 6 10.1128/AAC.31.7.1021 2821885
156 Tenover FC Fennell CL Lee L LeBlanc DJ Characterization of two plasmids from Campylobacter jejuni isolates that carry the aphA-7 kanamycin resistance determinant Antimicrob Agents Chemother 1992 36 712 6 10.1128/AAC.36.4.712 1503433
157 Tenover FC Filpula D Phillips KL Plorde JJ Cloning and sequencing of a gene encoding an aminoglycoside 6′-N-acetyltransferase from an R factor of Citrobacter diversus J Bacteriol 1988 170 471 3 2826403
158 Tenover FC Gilbert T O’Hara P Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes Plasmid 1989 22 52 8 10.1016/0147-619X(89)90035-8 2550983
159 Olkkola S Juntunen P Heiska H Hyytiäinen H Hänninen ML Mutations in the rpsL gene are involved in streptomycin resistance in Campylobacter coli Microb Drug Resist 2010 16 105 10 10.1089/mdr.2009.0128 20370506
160 Hannula M Hänninen ML Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli J Med Microbiol 2008 57 851 5 10.1099/jmm.0.47823-0 18566143
161 Pumbwe L Piddock LJV Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump FEMS Microbiol Lett 2002 206 185 9 10.1111/j.1574-6968.2002.tb11007.x 11814661
※ AI-Helper는 부적절한 답변을 할 수 있습니다.